Skip to main content

Table 2 Comparison of SD-OCT retinal and choroidal thickness subfield measurements in the SCD and control groups

From: Retinal and choroidal thickness in pediatric patients with sickle cell disease: a cross-sectional cohort study

 

SCD

Control

p value

Mean µm ± standard deviation (median)

Mean µm ± standard deviation (median)

Retinal thickness

 Central

256.39 ± 20.84 (256.00)

254.58 ± 18.89 (255.00)

0.748

 Superior parafovea

344.65 ± 21.13 (344.50)

340.06 ± 18.80 (337.00)

0.378

 Nasal parafovea

345.58 ± 17.21 (343.00)

334.00 ± 22.24 (330.00)

0.026*

 Inferior parafovea

343.07 ± 14.80 (342.00)

332.28 ± 18.26 (331.50)

0.011*

 Temporal parafovea

330.83 ± 16.02 (331.00)

322.14 ± 15.89 (320.00)

0.036*

 Superior perifovea

317.73 ± 13.24 (316.00)

311.18 ± 21.20 (305.00)

0.285

 Nasal perifovea

326.05 ± 15.06 (325.00)

319.75 ± 19.14 (318.50)

0.193

 Inferior perifovea

309.41 ± 17.15 (307.00)

300.96 ± 17.18 (299.00)

0.075

 Temporal perifovea

293.24 ± 11.09 (292.00)

291.60 ± 23.13 (286.00)

0.733

Choroidal thickness

 Subfovea

240.78 ± 21.27 (238.00)

275.87 ± 41.14 (262.50)

 < 0.001*

 Temporal parafovea

231.08 ± 21.01 (230.00)

266.16 ± 43.43 (255.00)

 < 0.001*

 Nasal parafovea

224.52 ± 17.97 (224.00)

251.44 ± 40.92 (236.00)

 < 0.001*

 Temporal perifovea

220.15 ± 30.47 (212.00)

247.28 ± 47.18 (228.00)

 < 0.001*

 Nasal perifovea

202.36 ± 17.53 (200.00)

220.69 ± 39.94 (214.50)

 < 0.001*

  1. *p < 0.05 is significant